FDA OKs Merck drug that prevents infection post-stem cell transplant – Business Insider
Medscape |
FDA OKs Merck drug that prevents infection post-stem cell transplant
Business Insider (Reuters) – Merck & Co Ltd’s drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug Administration, the drugmaker said on Thursday. Merck said the drug, which is expected to be … Letermovir (Prevymis) Okayed for Stem Cell Transplant InfectionMedscape FDA Approves Prevymis to Prevent CMV Among Stem Cell Transplant PatientsInfectious Disease Special Edition |
Medscape |
Letermovir (Prevymis) Okayed for Stem Cell Transplant Infection
Medscape In allogeneic HSCTs, stem cells are derived from another person’s bone marrow, as opposed to the patient’s own. The FDA puts the number of allogeneic HSCTs performed each year at more than 27,000 worldwide; roughly 8500 are performed each year in … Prevymis Approved to Prevent Virus in Patients Receiving Stem Cell TransplantsCuretoday.com FDA Approves Prevymis to Prevent CMV Among Stem Cell Transplant PatientsPharmacy Practice News |
Anglican Journal |
‘Food is culture, food is life, food is ritual’: Ethics of synthetic biology examined at conference
Anglican Journal Panelists discuss the ethical implications of synthetic biology. Left to right: Lucy Sharratt, co-ordinator of the Canadian Biotechnology Action Network, Nettie Wiebe, organic farmer, Nnimmo Bassey, director of Health of Mother Earth Foundation. Photo … |